Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs is a research paper published in Molecular Therapy — Nucleic Acids (2022). On theSindex it has a DataRank of 0.655. It has been cited 78 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.655
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1 R01 HL153988-01A1
In vivo delivery of engineered tRNAs for suppression of nonsense mutations
Cystic Fibrosis Foundation
Grant: LUECK18GO
Cystic Fibrosis Foundation
Grant: PORTER20F0
University of Iowa
Grant: PCT/US2018/059065
NHLBI NIH HHS
Grant: R01 HL153988
Cystic Fibrosis Foundation Therapeutics
Vertex Pharmaceuticals Inc
FWCI
5.41
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals